Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'thiazolidinediones' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 187 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Toseland, CDN; Campbell, S; Francis, I; Bugelski, PJ; Mehdi, N
      Comparison of adipose tissue changes following administration of rosiglitazone in the dog and rat

      DIABETES OBESITY & METABOLISM
    2. Alberti, KGMM
      Treating type 2 diabetes - today's targets, tomorrow's goals

      DIABETES OBESITY & METABOLISM
    3. Arner, P
      Free fatty acids - do they play a central role in type 2 diabetes?

      DIABETES OBESITY & METABOLISM
    4. Matthews, DR
      Insulin resistance and beta-cell function - a clinical perspective

      DIABETES OBESITY & METABOLISM
    5. Zinman, B
      PPAR gamma agonists in type 2 diabetes: how far have we come in 'preventing the inevitable'? A review of the metabolic effects of rosiglitazone

      DIABETES OBESITY & METABOLISM
    6. Kaplan, F; Al-Majali, K; Betteridge, DJ
      PPARs, insulin resistance and type 2 diabetes

      JOURNAL OF CARDIOVASCULAR RISK
    7. Mauvais-Jarvis, F; Andreelli, F; Hanaire-Broutin, H; Charbonnel, B; Girard, J
      Therapeutic perspectives for type 2 diabetes mellitus: Molecular and clinical insights

      DIABETES & METABOLISM
    8. Scheen, AJ
      Thiazolidinediones and liver toxicity

      DIABETES & METABOLISM
    9. Scheen, AJ
      The insulin sensitivity concept

      DIABETES & METABOLISM
    10. Reaven, GM
      Insulin resistance: why is it important to treat?

      DIABETES & METABOLISM
    11. Girard, J
      Mechanisms of action of thiazolidinediones

      DIABETES & METABOLISM
    12. Blickle, JF
      Thiazolidinediones: clinical data and perspectives

      DIABETES & METABOLISM
    13. Halimi, S
      Type 2 diabetes mellitus: Which place for thiazolidinediones in the therapeutic strategy?

      DIABETES & METABOLISM
    14. Rocchi, S; Picard, F; Vamecq, J; Gelman, L; Potier, N; Zeyer, D; Dubuquoy, L; Bac, P; Champy, MF; Plunket, KD; Leesnitzer, LM; Blanchard, SG; Desreumaux, P; Moras, D; Renaud, JP; Auwerx, J
      A unique PPAR gamma ligand with potent insulin-sensitizing yet weak adipogenic activity

      MOLECULAR CELL
    15. Inoue, M; Itoh, H; Tanaka, T; Chun, TH; Doi, K; Fukunaga, Y; Sawada, N; Yamshita, J; Masatsugu, K; Saito, T; Sakaguchi, S; Sone, M; Yamahara, K; Yurugi, T; Nakao, K
      Oxidized LDL regulates vascular endothelial growth factor expression in human macrophages and endothelial cells through activation of peroxisome proliferator-activated receptor-gamma

      ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
    16. Chen, Z; Ishibashi, S; Perrey, S; Osuga, J; Gotoda, T; Kitamine, T; Tamura, Y; Okazaki, H; Yahagi, N; Iizuka, Y; Shionoiri, F; Ohashi, K; Harada, K; Shimano, H; Nagai, R; Yamada, N
      Troglitazone inhibits atherosclerosis in apolipoprotein E-knockout mice - Pleiotropic effects on CD36 expression and HDL

      ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
    17. Berg, AH; Combs, TP; Du, XL; Brownlee, M; Scherer, P
      The adipocyte-secreted protein Acrp30 enhances hepatic insulin action

      NATURE MEDICINE
    18. Lenhard, JM
      PPAR gamma/RXR as a molecular target for diabetes

      RECEPTORS & CHANNELS
    19. Cronet, P; Petersen, JFW; Folmer, R; Blomberg, N; Sjoblom, K; Karlsson, U; Lindstedt, EL; Bamberg, K
      Structure of the PPAR alpha and -gamma ligand binding domain in complex with AZ 242; Ligand selectivity and agonist activation in the PPAR family

      STRUCTURE
    20. Rosenblatt, S; Miskin, B; Glazer, NB; Prince, MJ; Robertson, KE
      The impact of pioglitazone on glycemic control and atherogenic dyslipidemia in patients with type 2 diabetes mellitus

      CORONARY ARTERY DISEASE
    21. Vestergaard, H; Lund, S; Pedersen, O
      Rosiglitazone treatment of patients with extreme insulin resistance and diabetes mellitus due to insulin receptor mutations has no effects on glucoseand lipid metabolism

      JOURNAL OF INTERNAL MEDICINE
    22. Kraegen, EW; Cooney, GJ; Ye, J; Thompson, AL
      Triglycerides, fatty acids and insulin resistance - hyperinsulinemia

      EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES
    23. Kraegen, EW; Cooney, GJ; Ye, JM; Thompson, AL; Furler, SM
      The role of lipids in the pathogenesis of muscle insulin resistance and beta cell failure in type II diabetes and obesity

      EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES
    24. Raptis, SA; Dimitriadis, GD
      Oral hypoglycemic agents: insulin secretagogues, alpha-glucosidase inhibitors and insulin sensitizers

      EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES
    25. Debril, MB; Renaud, JP; Fajas, L; Auwerx, J
      The pleiotropic functions of peroxisome proliferator-activated receptor gamma

      JOURNAL OF MOLECULAR MEDICINE-JMM
    26. Fajas, L; Debril, MB; Auwerx, J
      PPAR gamma: An essential role in metabolic control

      NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES
    27. Naitoh, T; Kitahara, M; Tsuruzoe, N
      Tumor necrosis factor-alpha is induced through phorbol ester- and glycatedhuman albumin-dependent pathway in THP-1 cells

      CELLULAR SIGNALLING
    28. Nugent, C; Prins, JB; Whitehead, JP; Savage, D; Wentworth, JM; Chatterjee, VK; O'Rahilly, S
      Potentiation of glucose uptake, in 3T3-L1 adipocytes by PPAR gamma agonists is maintained in cells expressing a PPAR gamma dominant-negative mutant: Evidence for selectivity in the downstream responses to PPAR gamma activation

      MOLECULAR ENDOCRINOLOGY
    29. Chvojkova, S; Kazdova, L; Divisova, J
      A comparison of the effects of troglitazone and vitamin E on the fatty acid composition of serum phospholipids in an experimental model of insulin resistance

      PHYSIOLOGICAL RESEARCH
    30. Kushibiki, S; Hodate, K; Shingu, H; Ueda, Y; Shinoda, M; Mori, Y; Itoh, T; Yokomizo, Y
      Insulin resistance induced in dairy steers by tumor necrosis factor alpha is partially reversed by 2,4-thiazolidinedione

      DOMESTIC ANIMAL ENDOCRINOLOGY
    31. Perfetti, R; Chamie, K
      Enhancing insulin action: From chemical elements to thiazolidinediones

      JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION
    32. Benavides, A; Martinez, R; Jimenez-Vazqeuz, HA; Delgado, F; Tamariz, J
      Synthesis and cycloaddition reactions of new captodative olefins N-substituted 5-alkylidene-1,3-oxazolidine-2,4-diones

      HETEROCYCLES
    33. Bar-Tana, J
      Peroxisome proliferator-activated receptor gamma (PPAR gamma) activation and its consequences in humans

      TOXICOLOGY LETTERS
    34. Sorbera, LA; Leeson, PA; Martin, L; Castaner, J
      Farglitazar - Antidiabetic, PPAR gamma agonist

      DRUGS OF THE FUTURE
    35. Haskins, JR; Rowse, P; Rahbari, R; de la Iglesia, FA
      Thiazolidinedione toxicity to isolated hepatocytes revealed by coherent multiprobe fluorescence microscopy and correlated with multiparameter flow cytometry of peripheral leukocytes

      ARCHIVES OF TOXICOLOGY
    36. Vander Lugt, JT; Gomez-Marquez, J; Caldon, J; Louters, LL
      Combined effects of troglitazone and muscle contraction on insulin sensitization in Balb-c mouse muscle

      BIOCHIMIE
    37. Rahimian, R; Masih-Khan, E; Lo, M; van Breemen, C; McManus, BM; Dube, GP
      Hepatic over-expression of peroxisome proliferator activated receptor gamma 2 in the ob/ob mouse model of non-insulin dependent diabetes mellitus

      MOLECULAR AND CELLULAR BIOCHEMISTRY
    38. Chatterjee, VKK
      Resistance to thyroid hormone, and peroxisome-proliferator-activated receptor gamma resistance

      BIOCHEMICAL SOCIETY TRANSACTIONS
    39. Bedoucha, M; Atzpodien, E; Boelsterli, UA
      Diabetic KKA(y) mice exhibit increased hepatic PPAR gamma 1 gene expression and develop hepatic steatosis upon chronic treatment with antidiabetic thiazolidinediones

      JOURNAL OF HEPATOLOGY
    40. Bunnag, P; Puavilai, G; Chanprasertyotin, S; Chandraprasert, S; Suwanwalaikorn, S; Suthijumroon, A; Benjasuratwong, Y; Boonyavarakul, A; Nitiyanant, W; Sriussadaporn, S; Deerochanawong, C
      Effects of troglitazone in patients with type 2 diabetes mellitus not adequately controlled by sulfonylureas

      DIABETES RESEARCH AND CLINICAL PRACTICE
    41. Yokoyama, I; Yonekura, K; Moritan, T; Tateno, M; Momose, T; Ohtomo, K; Inoue, Y; Nagai, R
      Troglitazone improves whole-body insulin resistance and skeletal muscle glucose use in type II diabetic patients

      JOURNAL OF NUCLEAR MEDICINE
    42. Phillips, LS; Grunberger, G; Miller, E; Patwardhan, R; Rappaport, EB; Salzman, A
      Once- and twice-daily dosing with rosiglitazone improves glycemic control in patients with type 2 diabetes

      DIABETES CARE
    43. Chilcott, J; Tappenden, P; Jones, ML; Wight, JP
      A systematic review of the clinical effectiveness of pioglitazone in the treatment of type 2 diabetes mellitus

      CLINICAL THERAPEUTICS
    44. Gale, EAM
      Lessons from the glitazones: a story of drug development

      LANCET
    45. Joffe, BI; Panz, VR; Raal, FJ
      From lipodystrophy syndromes to diabetes mellitus

      LANCET
    46. Inglis, AML; Miller, AK; Culkin, KT; Finnerty, D; Patterson, SD; Jorkasky, DK; Freed, MI
      Lack of effect of rosiglitazone on the pharmacokinetics of oral contraceptives in healthy female volunteers

      JOURNAL OF CLINICAL PHARMACOLOGY
    47. Prueksaritanont, T; Vega, JM; Zhao, J; Gagliano, K; Kuznetsova, O; Musser, B; Amin, RD; Liu, L; Roadcap, BA; Dilzer, S; Lasseter, KC; Rogers, JD
      Interactions between simvastatin and troglitazone or pioglitazone in healthy subjects

      JOURNAL OF CLINICAL PHARMACOLOGY
    48. Mudaliar, S; Henry, RR
      New oral therapies for type 2 diabetes mellitus: The glitazones or insulinsensitizers

      ANNUAL REVIEW OF MEDICINE
    49. Gouni-Berthold, I; Berthold, HK; Weber, AA; Ko, Y; Seul, C; Vetter, H; Sachinidis, A
      Troglitazone and rosiglitazone induce apoptosis of vascular smooth muscle cells through an extracellular signal-regulated kinase-independent pathway

      NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
    50. Codner, E; Loviscach, M; Ciaraldi, TP; Rehman, N; Carter, L; Mudaliar, S; Henry, RR
      Retinoid X receptor expression in skeletal muscle of nondiabetic, obese and type 2 diabetic individuals

      METABOLISM-CLINICAL AND EXPERIMENTAL
    51. Nakamura, T; Ushiyama, C; Osada, S; Hara, M; Shimada, N; Koide, H
      Pioglitazone reduces urinary podocyte excretion in type 2 diabetes patients with microalbuminuria

      METABOLISM-CLINICAL AND EXPERIMENTAL
    52. Costa, B
      A new therapeutical approach in type 2 diabetes

      MEDICINA CLINICA
    53. Bebernitz, GR; Argentieri, G; Battle, B; Brennan, C; Balkan, B; Burkey, BF; Eckhardt, M; Gao, JP; Kapa, P; Strohschein, RJ; Schuster, HF; Wilson, M; Xu, DD
      The effect of 1,3-diaryl-[1H]-pyrazole-4-acetamides on glucose utilizationin ob/ob mice

      JOURNAL OF MEDICINAL CHEMISTRY
    54. Lebovitz, HE; Dole, JF; Patwardhan, R; Rappaport, EB; Freed, MI
      Rosiglitazone monotherapy is effective in patients with type 2 diabetes

      JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM
    55. Yamauchi, T; Kamon, J; Waki, H; Murakami, K; Motojima, K; Komeda, K; Ide, T; Kubota, N; Terauchi, Y; Tobe, K; Miki, H; Tsuchida, A; Akanuma, Y; Nagai, R; Kimura, S; Kadowaki, T
      Mechanisms by which both heterozygous peroxisome proliferator-activated receptor gamma (PPAR gamma) deficiency and PPAR gamma agonist improve insulinresistance.

      JOURNAL OF BIOLOGICAL CHEMISTRY
    56. Fukunaga, Y; Itoh, H; Doi, K; Tanaka, T; Yamashita, J; Chun, TH; Inoue, M; Masatsugu, K; Sawada, N; Saito, T; Hosoda, K; Kook, H; Ueda, M; Nakao, K
      Thiazolidinediones, peroxisome proliferator-activated receptor gamma agonists, regulate endothelial cell growth and secretion of vasoactive peptides

      ATHEROSCLEROSIS
    57. Kitakoshi, K; Oshida, Y; Nakai, N; Han, YQ; Sato, Y
      Effects of troglitazone and voluntary running on insulin resistance induced high fat diet in the rat

      HORMONE AND METABOLIC RESEARCH
    58. Yeow, K; Phillips, B; Dani, C; Cabane, C; Amri, EZ; Derijard, B
      Inhibition of myogenesis enables adipogenic trans-differentiation in the C2Cl2 myogenic cell line

      FEBS LETTERS
    59. Rieusset, J; Roques, M; Bouzakri, K; Chevillotte, E; Vidal, H
      Regulation of p85 alpha phosphatidylinositol-3-kinase expression by peroxisome proliferator-activated receptors (PPARs) in human muscle cells

      FEBS LETTERS
    60. Camp, HS; Chaudhry, A; Leff, T
      A novel potent antagonist of peroxisome proliferator-activated receptor gamma blocks adipocyte differentiation but does not revert the phenotype of terminally differentiated adipocytes

      ENDOCRINOLOGY
    61. Kanoh, Y; Bandyopadhyay, G; Sajan, MP; Standaert, ML; Farese, RV
      Rosiglitazone, insulin treatment, and fasting correct defective activationof protein kinase C-zeta/lambda by insulin in vastus lateralis muscles andadipocytes of diabetic rats

      ENDOCRINOLOGY
    62. Way, JM; Harrington, WW; Brown, KK; Gottschalk, WK; Sundseth, SS; Mansfield, TA; Ramachandran, RK; Willson, TM; Kliewer, SA
      Comprehensive messenger ribonucleic acid profiling reveals that peroxisomeproliferator-activated receptor gamma activation has coordinate effects ongene expression in multiple insulin-sensitive tissues

      ENDOCRINOLOGY
    63. Iwata, M; Haruta, T; Usui, I; Takata, Y; Takano, A; Uno, T; Kawahara, J; Ueno, E; Sasaoka, T; Ishibashi, O; Kobayashi, M
      Pioglitazone ameliorates tumor necrosis factor-alpha-induced insulin resistance by a mechanism independent of adipogenic activity of peroxisome proliferator-activated receptor-gamma

      DIABETES
    64. Yang, C; Chang, TJ; Chang, JC; Liu, MW; Tai, TY; Hsu, WH; Chuang, LM
      Rosiglitazone (BRL 49653) enhances insulin secretory response via phosphatidylinositol 3-kinase pathway

      DIABETES
    65. Davies, GF; Khandelwal, RL; Wu, LY; Juurlink, BHJ; Roesler, WJ
      Inhibition of phosphoenolpyruvate carboxykinase (PEPCK) gene expression bytroglitazone: a peroxisome proliferator-activated receptor-gamma (PPAR gamma)-independent, antioxidant-related mechanism

      BIOCHEMICAL PHARMACOLOGY
    66. Moore, GBT; Chapman, H; Holder, JC; Lister, CA; Piercy, V; Smith, SA; Clapham, JC
      Differential regulation of adipocytokine mRNAs by rosiglitazone in db/db mice

      BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
    67. Kausch, C; Krutzfeldt, J; Witke, A; Rettig, A; Bachmann, O; Rett, K; Matthaei, S; Machicao, F; Haring, HU; Stumvoll, M
      Effects of troglitazone on cellular differentiation, insulin signaling, and glucose metabolism in cultured human skeletal muscle cells

      BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
    68. Bozdag-Dundar, O; Waheed, A; Verspohl, EJ; Ertan, R
      Synthesis and hypoglycemic activity of some new flavone derivatives - 4th Communication: 6-Flavonyl-2,4-thiazolidinediones

      ARZNEIMITTEL-FORSCHUNG-DRUG RESEARCH
    69. Smith, SA; Lister, CA; Toseland, CDN; Buckingham, RE
      Rosiglitazone prevents the onset of hyperglycaemia and proteinuria in the Zucker diabetic fatty rat

      DIABETES OBESITY & METABOLISM
    70. Goldstein, BJ
      Rosiglitazone

      INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
    71. Murphy, E; Nolan, JJ
      Insulin sensitiser drugs

      EXPERT OPINION ON INVESTIGATIONAL DRUGS
    72. Nass, CM; Blumenthal, RS
      Glitazones and the potential improvement of lipid profiles in diabetes patients at high risk for cardiovascular disease

      AMERICAN JOURNAL OF MANAGED CARE
    73. Yanagisawa, H; Takamura, M; Yamada, E; Fujita, S; Fujiwara, T; Yachi, M; Isobe, A; Hagisawa, Y
      Novel oximes having 5-benzyl-2,4-thiazolidinedione as antihyperglycemic agents: Synthesis and structure-activity relationship

      BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
    74. Goke, B
      Type 2 diabetes: Are current oral treatment options sufficient?

      EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES
    75. Belcher, G; Matthews, DR
      Safety and tolerability of pioglitazone

      EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES
    76. Reaven, GM
      Insulin resistance - how important is it to treat?

      EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES
    77. Kimura, M; Daimon, M; Tominaga, M; Manaka, H; Sasaki, H; Kato, T
      Thiazolidinediones exert different effects on insulin resistance between dexamethasone-treated rats and Wistar fatty rats

      ENDOCRINE JOURNAL
    78. Scheen, AJ
      Treatment of diabetes in patients with severe obesity

      BIOMEDICINE & PHARMACOTHERAPY
    79. Bailey, CJ
      The rise and fall of troglitazone

      DIABETIC MEDICINE
    80. Nolan, JJ; Jones, NP; Patwardhan, R; Deacon, LF
      Rosiglitazone taken once daily provides effective glycaemic control in patients with Type 2 diabetes mellitus

      DIABETIC MEDICINE
    81. Berger, J; Patel, HV; Woods, J; Hayes, NS; Parent, SA; Clemas, J; Leibowitz, MD; Elbrecht, A; Rachubinski, RA; Capone, JP; Moller, DE
      A PPAR gamma mutant serves as a dominant negative inhibitor of PPAR signaling and is localized in the nucleus

      MOLECULAR AND CELLULAR ENDOCRINOLOGY
    82. Shimokawa, T; Kato, M; Kagami, M; Ueda, Y; Kurosaki, E; Maruyama, T; Shibasaki, M; Katoh, M
      Glucose uptake stimulator YM-138552 activates gene expression and translocation of glucose transporter isotype

      DRUG DEVELOPMENT RESEARCH
    83. Fukunaga, Y; Itoh, H; Hosoda, K; Doi, K; Matsuda, J; Son, C; Yamashita, J; Chun, TH; Tanaka, T; Inoue, M; Masatsugu, K; Saito, T; Sawada, N; Nakao, K
      Altered gene expression of uncoupling protein-2 and-3 in stroke-prone spontaneously hypertensive rats

      JOURNAL OF HYPERTENSION
    84. Akazawa, S; Sun, FY; Ito, M; Kawasaki, E; Eguchi, K
      Efficacy of troglitazone on body fat distribution in type 2 diabetes

      DIABETES CARE
    85. Malinowski, JM; Bolesta, S
      Rosiglitazone in the treatment of type 2 diabetes mellitus: A critical review

      CLINICAL THERAPEUTICS
    86. Burkey, BF; Dong, M; Gagen, K; Eckhardt, M; Dragonas, N; Chen, W; Grosenstein, P; Argentieri, G; de Souza, CJ
      Effects of pioglitazone on promoting energy storage, not expenditure, in brown adipose tissue of obese fa/fa Zucker rats: Comparison to CL 316,243

      METABOLISM-CLINICAL AND EXPERIMENTAL
    87. Thampy, GK; Haas, MJ; Mooradian, AD
      Troglitazone stimulates acetyl-CoA carboxylase activity through a post-translational mechanism

      LIFE SCIENCES
    88. Johnson, BA; Wilson, EM; Li, Y; Moller, DE; Smith, RG; Zhou, GC
      Ligand-induced stabilization of PPAR gamma monitored by NMR spectroscopy: Implications for nuclear receptor activation

      JOURNAL OF MOLECULAR BIOLOGY
    89. Oguchi, M; Wada, K; Honma, H; Tanaka, A; Kaneko, T; Sakakibara, S; Ohsumi, J; Serizawa, N; Fujiwara, T; Horikoshi, H; Fujita, T
      Molecular design, synthesis, and hypoglycemic activity of a series of thiazolidine-2,4-diones

      JOURNAL OF MEDICINAL CHEMISTRY
    90. Hauser, S; Adelmant, G; Sarraf, P; Wright, HM; Mueller, E; Spiegelman, BM
      Degradation of the peroxisome proliferator-activated receptor gamma is linked to ligand-dependent activation

      JOURNAL OF BIOLOGICAL CHEMISTRY
    91. Baumann, CA; Chokshi, N; Saltiel, AR; Ribon, V
      Cloning and characterization of a functional peroxisome proliferator activator receptor-gamma-responsive element in the promoter of the CAP gene

      JOURNAL OF BIOLOGICAL CHEMISTRY
    92. Leibowitz, MD; Fievet, C; Hennuyer, N; Peinado-Onsurbe, J; Duez, H; Berger, J; Cullinan, CA; Sparrow, CP; Baffic, J; Berger, GD; Santini, C; Marquis, RW; Tolman, RL; Smith, RG; Moller, DE; Auwerx, J
      Activation of PPAR delta alters lipid metabolism in db/db mice

      FEBS LETTERS
    93. Memon, RA; Tecott, LH; Nonogaki, K; Beigneux, A; Moser, AH; Grunfeld, C; Feingold, KR
      Up-regulation of peroxisome proliferator-activated receptors (PPAR-alpha) and PPAR-gamma messenger ribonucleic acid expression in the liver in murineobesity: Troglitazone induces expression of PPAR-gamma-responsive adipose tissue-specific genes in the liver of obese diabetic mice

      ENDOCRINOLOGY
    94. Gillies, PS; Dunn, CJ
      Pioglitazone

      DRUGS
    95. Dubois, M; Pattou, F; Kerr-Conte, J; Gmyr, V; Vandewalle, B; Desreumaux, P; Auwerx, J; Schoonjans, K; Lefebvre, J
      Expression of peroxisome proliferator-activated receptor gamma (PPAR gamma) in normal human pancreatic islet cells

      DIABETOLOGIA
    96. Raskin, P; Rappaport, EB; Cole, ST; Yan, Y; Patwardhan, R; Freed, MI
      Rosiglitazone short-term monotherapy lowers fasting and post-prandial glucose in patients with Type II diabetes

      DIABETOLOGIA
    97. Petersen, KF; Krssak, M; Inzucchi, S; Cline, GW; Dufour, S; Shulman, GI
      Mechanism of troglitazone action in type 2 diabetes

      DIABETES
    98. Khalfallah, Y; Fages, S; Laville, M; Langin, D; Vidal, H
      Regulation of uncoupling protein-2 and uncoupling protein-3 mRNA expression during lipid infusion in human skeletal muscle and subcutaneous adipose tissue

      DIABETES
    99. Law, RE; Goetze, S; Xi, XP; Jackson, S; Kawano, Y; Demer, L; Fishbein, MC; Meehan, WP; Hsueh, WA
      Expression and function of PPAR gamma in rat and human vascular smooth muscle cells

      CIRCULATION
    100. McKay, NG; Kinsella, JM; Campbell, CM; Ashford, MLJ
      Sensitivity of Kir6.2-SUR1 currents, in the absence and presence of sodiumazide, to the K-ATP channel inhibitors, ciclazindol and englitazone

      BRITISH JOURNAL OF PHARMACOLOGY


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 06/06/20 alle ore 11:19:06